Real vaccines in the real world: tuberculosis vaccines move south

References

• Sander C, McShane H. Translational mini-review series on vaccines: development and evaluation of improved vaccines against tuberculosis. Clin. Exp. Immunol.147, 401–411 (2007).
   PubMed Web of Science ®Google Scholar
• Reece ST, Kaufmann SH. Rational design of vaccines against tuberculosis directed by basic immunology. Int. J. Med. Microbiol.298, 143–150 (2008).
   PubMed Web of Science ®Google Scholar
• Reed MB, Domenech P, Manca C et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature431, 84–87 (2004).
   PubMed Web of Science ®Google Scholar
• Caws M, Thwaites G, Dunstan S et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosisPLoS Pathog.4, e1000034 (2008).
   PubMed Web of Science ®Google Scholar
• Portaels F, Meyers WM, Ablordey A et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl. Trop. Dis.2, e178 (2008).
   PubMed Web of Science ®Google Scholar
• Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev.5, 1–25 (1992).
   PubMed Web of Science ®Google Scholar
• Chilima BZ, Clark IM, Floyd S, Fine PE, Hirsch PR. Distribution of environmental mycobacteria in Karonga District, northern Malawi. Appl. Environ. Microbiol.72, 2343–2350 (2006).
   Google Scholar
• September SM, Brozel VS, Venter SN. Diversity of non-tuberculoid mycobacterium species in biofilms of urban and semiurban drinking water distribution systems. Appl. Environ. Microbiol.70, 7571–7573 (2004).
   PubMed Web of Science ®Google Scholar
• Hatherill M, Hawkridge T, Whitelaw A et al. Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS ONE1, e21 (2006).
   PubMed Web of Science ®Google Scholar
• Martin-Casabona N, Bahrmand AR, Bennedsen J et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int. J. Tuberc. Lung Dis.8, 1186–1193 (2004).
   PubMed Web of Science ®Google Scholar
• Yates MD, Pozniak A, Uttley AH, Clarke R, Grange JM. Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973–1993. Int. J. Tuberc. Lung Dis.1, 75–80 (1997).
   Google Scholar
• Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun.64, 16–22 (1996).
   PubMed Web of Science ®Google Scholar
• Andersen P, Doherty TM. The success and failure of BCG – implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol.3, 656–662 (2005).
   PubMed Web of Science ®Google Scholar
• Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis.99(Suppl. 4), 1–132 (1969).
   PubMed Web of Science ®Google Scholar
• Edwards LB, Acquaviva FA, Livesay VT. Identification of tuberculous infected. Dual tests and density of reaction. Am. Rev. Respir. Dis.108, 1334–1339 (1973).
   PubMed Web of Science ®Google Scholar
• Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis.94, 553–568 (1966).
   PubMed Web of Science ®Google Scholar
• Brandt L, Feino Cunha J, Weinreich Olsen A et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun.70, 672–678 (2002).
   PubMed Web of Science ®Google Scholar
• Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine20, 1126–1133 (2002).
   PubMed Web of Science ®Google Scholar
• Demangel C, Garnier T, Rosenkrands I, Cole ST. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect. Immun.73, 2190–2196 (2005).
   PubMed Web of Science ®Google Scholar
• Ponnighaus JM, Fine PE, Sterne JA et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet339, 636–639 (1992).
   PubMed Web of Science ®Google Scholar
• Black GF, Weir RE, Floyd S et al. BCG-induced increase in interferon-γ response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet359, 1393–1401 (2002).
   PubMed Web of Science ®Google Scholar
• Black GF, Dockrell HM, Crampin AC et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis.184, 322–329 (2001).
   PubMed Web of Science ®Google Scholar
• Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet346, 1339–1345 (1995).
   PubMed Web of Science ®Google Scholar
• Weir RE, Black GF, Nazareth B et al. The influence of previous exposure to environmental mycobacteria on the interferon-γ response to bacille Calmette–Guérin vaccination in southern England and northern Malawi. Clin. Exp. Immunol.146, 390–399 (2006).
   PubMed Web of Science ®Google Scholar
• Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect. Immun.75, 2833–2840 (2007).
   PubMed Web of Science ®Google Scholar
• Flaherty DK, Vesosky B, Beamer GL, Stromberg P, Turner J. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol.80, 1262–1271 (2006).
   PubMed Web of Science ®Google Scholar
• Moore SE, Collinson AC, Tamba N’Gom P, Aspinall R, Prentice AM. Early immunological development and mortality from infectious disease in later life. Proc. Nutr. Soc.65, 311–318 (2006).
   Google Scholar
• Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol.37, 113–119 (2008).
   PubMed Web of Science ®Google Scholar
• Moore SE, Collinson AC, Fulford AJ et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop. Med. Int. Health11, 1529–1541 (2006).
   PubMed Web of Science ®Google Scholar
• Miles DJ, van der Sande M, Crozier S et al. Effect of antenatal and postnatal environment on CD4 T-cell responses to BCG in healthy Gambian infants. Clin. Vaccine Immunol.15(6), 995–1002 (2008).
   Google Scholar
• Collinson AC, Moore SE, Cole TJ, Prentice AM. Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr.92, 1014–1020 (2003).
   PubMed Web of Science ®Google Scholar
• Ngom PT, Collinson AC, Pido-Lopez J, Henson SM, Prentice AM, Aspinall R. Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers’ breast milk. Am. J. Clin. Nutr.80, 722–728 (2004).
   Google Scholar
• Kassu A, Tsegaye A, Wolday D et al. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin. Exp. Immunol.132, 113–119 (2003).
   Google Scholar
• Messele T, Abdulkadir M, Fontanet al. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin. Exp. Immunol.115, 443–450 (1999).
   PubMed Web of Science ®Google Scholar
• Wild CP. Aflatoxin exposure in developing countries: the critical interface of agriculture and health. Food Nutr. Bull.28(Suppl. 2), S372–S380 (2007).
   PubMed Web of Science ®Google Scholar
• Hetherington SV, Lepow ML. Correlation between antibody affinity and serum bactericidal activity in infants. J. Infect. Dis.165, 753–756 (1992).
   Google Scholar
• Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr. Infect. Dis. J.17(Suppl. 9), S117–S122 (1998).
   PubMed Web of Science ®Google Scholar
• Lee YC, Newport MJ, Goetghebuer T et al. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins. Vaccine24, 5335–5340 (2006).
   PubMed Web of Science ®Google Scholar
• Marchant A, Pihlgren M, Goetghebuer T et al. Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J. Infect. Dis.193, 1598–1605 (2006).
   PubMed Web of Science ®Google Scholar
• Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun.5, 122–129 (2004).
   PubMed Web of Science ®Google Scholar